MaxCyte Sees $17M-$19M Annual Savings through Restructuring, Reiterates SPL Revenue Guidance

miércoles, 12 de noviembre de 2025, 7:22 pm ET1 min de lectura
MXCT--

MaxCyte reported $6.8 million in total revenue for Q3, with $6.4 million in core revenue and $0.4 million in SPL program-related revenue. CEO Maher Masoud stated the quarter was "a bit light due to timing of large deals." The company expects to achieve $17-19 million in annualized savings through restructuring, while reiterating its SPL revenue guidance.

MaxCyte Sees $17M-$19M Annual Savings through Restructuring, Reiterates SPL Revenue Guidance

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios